ASHP Accredited 

Program Director: Meera Mehta, PharmD, BCIDP
Email: meera.mehta@wvumedicine.org 
Positions: 1
Application Due: January 2, 2025
Starting Date: July 1, 2025
Estimated Stipend: $53,000 + benefits

Purpose Statement & Program Overview

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

The PGY2 Infectious Diseases Pharmacy Residency at WVU Medicine is an organized, directed, accredited program that builds upon the infectious disease related competencies established in Post-Graduate Year One of residency training. The PGY2 Infectious Diseases Program increases the resident’s depth of knowledge, skills, attitudes, and abilities to raise the resident’s level of expertise in medication therapy management and clinical leadership in the infectious disease setting. The resident will exhibit a commitment to the profession of pharmacy and be able to develop their own personal plan for professional development.  Residents will conduct their daily practice with a high level of maturity and leadership. Residents completing this program will have the knowledge, skills, and abilities that are highly marketable. 

Rotational Learning Experiences:

The program is a twelve-month, postgraduate training experience composed of 8-blocks of required and elective rotational learning experiences.

Required Rotational Experiences:

  • Infectious Diseases Consult Service (2 blocks x 5 weeks)
  • Antimicrobial Stewardship & Microbiology Lab Orientation (1 block x 5 weeks)
  • Medical Intensive Care (MICU) (1 blocks x 5 weeks)
  • Bone Marrow Transplant (BMT) (1 block x 5 weeks)
  • Outpatient Parenteral Antimicrobial Therapy (OPAT) Service (1 block x 5 weeks)

Elective Rotational Experiences:

  • International Infectious Diseases (Cape Town, South Africa)
  • Pediatric Infectious Diseases
  • An additional Infectious Diseases Consult Service, Antimicrobial Stewardship, or OPAT block
  • Internal Medicine

Longitudinal Learning Experiences:

  • Ryan White HIV Clinic
  • Antimicrobial Stewardship & Quality Improvement
  • Academic Teaching and Continuing Education (CE) Presentation
  • Medication Use Evaluation (MUE) and Research Projects
  • Hospital Pharmacy Practice (Staffing)

PGY2 Infectious Diseases Residency Director


Meera Mehta is originally from London, England and is currently an Infectious Diseases Clinical Specialist at WVU Medicine in Morgantown, West Virginia. In 2017, she created the Outpatient Parenteral Antimicrobial Therapy (OPAT) program at her institution and since then has also implemented tracking and reporting quality assurance and performance improvement (QAPI) metrics for the program to ensure optimization of OPAT services. She also plays a role in Complex Oral Antimicrobial Therapy (COpAT), antimicrobial stewardship, and treating infections in persons who inject drugs (PWID). Meera has her own infectious diseases podcast called “Infectious Conversations” where important infectious diseases topics are discussed with experts on a monthly basis. Additionally, she serves on the Infectious Disease Specialty Council for the Board of Pharmacy Specialties (BPS) Board Certified Infectious Diseases Pharmacist (BCIDP) exam.

PGY2 Infectious Diseases Residency Program Coordinator

Megan Hardy, PharmD, BCIDP is an Infectious Diseases Clinical Pharmacy Specialist at WVU Medicine in Morgantown, West Virginia. Her role as an Infectious Diseases specialist includes involvement with Outpatient Parenteral Antimicrobial Therapy (OPAT), Complex Oral Antimicrobial Therapy (COpAT), and antimicrobial stewardship. She joined WVU Medicine in 2023 following completion of her PGY2 Infectious Diseases Residency at Henry Ford Health in Detroit, Michigan. Prior to PGY2, she graduated from West Virginia University School of Pharmacy in 2021 and completed her PGY1 Clinical Pharmacy Residency at Cleveland Clinic Akron General in Akron, Ohio.